Astrana Health Inc. Common Stock vs. Bowman Consulting Group Ltd. Common Stock
ASTH
Astrana Health Inc. Common Stock
$36.37 +5.60%
VS BWMNBowman Consulting Group Ltd. Common Stock
$42.57 +0.02%
Astrana Health Inc. Common Stock and Bowman Consulting Group Ltd. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ASTH | BWMN | |
|---|---|---|
| Market Cap | $1.80 billion | $737.90 million |
| Revenue (TTM) | — | $527.60 million |
| Net Income (TTM) | — | $7.38 million |
ASTH leads on 1 of 1 size & scale factors.
Valuation
| ASTH | BWMN | |
|---|---|---|
| P/E Ratio | — | 106.42 |
| Price / Book | — | 2.88 |
| Price / Sales | — | 1.40 |
ASTH and BWMN split the valuation factors evenly.
Profitability
| ASTH | BWMN | |
|---|---|---|
| Net Margin | — | 1.40% |
| Return on Equity | — | 2.88% |
ASTH and BWMN split the profitability factors evenly.
Risk & Sentiment
| ASTH | BWMN | |
|---|---|---|
| Short Interest | 4.73% | 0.00% |
BWMN leads on 1 of 1 risk & sentiment factors.
Dig deeper: ASTH overview, ASTH financials, BWMN overview, BWMN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.